Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In STELLAR-4 (NCT03053063), the primary endpoint was achieved in 14% (18 mg, p = 0.56), 13% (6 mg, p = 0.93), and 13% (placebo) of patients
Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes
Wait for private UK availability of retatrutide Private prescriptions for both Wegovy and Mounjaro became available within weeks of MHRA approval, well before NHS access
Molecular basis for some physical properties of alginates in the gel state
doi: 10.26502/aimr.0189
US$ 29.12
US$ 28.74
US$ 23.78
US$ 23.70
US$ 22.26
US$ 20.71
